Status: Recruiting
Observational Cohort Study on Ocular Chronic Graft-Versus-Host Disease
This study is a multicenter, prospective, observational cohort study designed to enroll a total of 340 patients undergoing allogeneic hematopoietic stem cell transplantation. Through comprehensive evaluations by hematology departments, ophthalmology departments, and patient-reported outcomes, the study aims to assess patient-reported outcomes, overall incidence, risk factors, and other clinical outcomes in patients with chronic ocular graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Participants needed: 340
Trial details
Age: 14+Biological sex: AllType: ObservationalSponsor: Ruijin HospitalUpdated: Aug 31, 2026Locations: 1Duration: 2 Years
Eligibility criteria
Age ≥14 years, both genders eligible; [+3]
Preexisting moderate-to-severe ocular surface disease prior to transplantation; [+3]